Mao et al38 discovered that miR‐181a‐5p interacts with fibroblast growth factor receptor 3 (FGFR3) to promote the progression of bladder cancer through the activation of the STAT3 pathway. Here, FGFR3 is linked to urinary bladder carcinoma.